UNCONTROLLED WHEN PRINTED
Introduction
Compounded medication produced for pre-drawn use in maintaining sedation post RSI.
Morphine
- A narcotic analgesic acting on CNS by binding with opioid receptors
- Also combines to cause respiratory depression, vasodilation, decreases gag reflex and slows AV node conduction
Midazolam
- A water-soluble benzodiazepine that has anxiolytic, sedative and anticonvulsive characteristics. This is due to its bonding with receptors in the CNS; its action to increase the inhibitory effect of the g-aminobutyric acid (GABA) neurotransmitter on the GABA receptors and subsequent membrane threshold.
- Midazolam is lipid-soluble in physiological pH and it reaches the CNS quickly
Indications
- Maintain sedation post RSI
Contraindications
- Hypersensitivity
Precautions / Notes
- Elderly patients
- Hypotension
- Patients on monoamine oxidase inhibitor
- Renal failure
Management
Critical Care Paramedic only
- Infusion Dose: 0.1-0.2mg/kg/hr IV/IO
- Bolus Dose: 0.05-0.1mg/kg PRN
Special Considerations
- Hypotension
References
References
Presentation
- 15mL pre-drawn syringe
- 15mg Midazolam
- 15mg Morphine
Concentration:
- 1mg Midazolam & 1mg Morphine per 1mL of solution
| Colour assist: |
|---|
Discarding unused medication must be witnessed and countersigned by attendant and credible witness.
Document Control
Directorate
Clinical Services
Responsible Manager
Deputy Medical Director
Date of Issue
Date of Expiry
St John Ambulance Western Australia Ltd © Copyright 2020, All Rights Reserved